| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
70,650,000 |
| Market
Cap: |
4.01(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$38.62 - $89.12 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
61,438 |
159,721 |
184,721 |
409,721 |
| Total Sell Value |
$4,291,798 |
$10,834,513 |
$12,456,407 |
$25,314,056 |
| Total People Sold |
3 |
3 |
3 |
3 |
| Total Sell Transactions |
7 |
12 |
13 |
22 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dylan-Hyde Tyler |
Chief Legal Officer |
• – – |
2017-08-07 |
4 |
AS |
$18.56 |
$245,209 |
D/D |
(13,210) |
154,517 |
|
- |
|
| Dylan-Hyde Tyler |
Chief Legal Officer |
• – – |
2017-08-04 |
4 |
AS |
$18.55 |
$8,848 |
D/D |
(477) |
167,727 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-08-04 |
4 |
AS |
$18.50 |
$56,758 |
I/I |
(3,068) |
2,226,345 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-08-03 |
4 |
AS |
$17.77 |
$842,458 |
I/I |
(47,409) |
2,229,413 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-08-01 |
4 |
AS |
$17.50 |
$4,620 |
I/I |
(264) |
2,276,822 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-31 |
4 |
AS |
$17.51 |
$91,871 |
I/I |
(5,248) |
2,277,086 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-28 |
4 |
AS |
$17.65 |
$7,060 |
I/I |
(400) |
2,282,334 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-27 |
4 |
AS |
$17.63 |
$721,074 |
I/I |
(40,912) |
2,282,734 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-26 |
4 |
AS |
$17.63 |
$418,607 |
I/I |
(23,744) |
2,323,646 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-25 |
4 |
AS |
$17.52 |
$160,939 |
I/I |
(9,186) |
2,347,390 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-14 |
4 |
AS |
$16.82 |
$609,389 |
I/I |
(36,230) |
2,356,576 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-13 |
4 |
AS |
$16.87 |
$567,321 |
I/I |
(33,629) |
2,392,806 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-12 |
4 |
AS |
$16.60 |
$296,675 |
I/I |
(17,872) |
2,408,563 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-11 |
4 |
AS |
$16.52 |
$233,262 |
I/I |
(14,120) |
2,426,435 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-07-05 |
4 |
AS |
$16.26 |
$69,170 |
I/I |
(4,254) |
2,440,555 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-29 |
4 |
AS |
$16.52 |
$191,797 |
I/I |
(11,610) |
2,444,809 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-28 |
4 |
AS |
$17.04 |
$538,328 |
I/I |
(31,592) |
2,456,419 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-27 |
4 |
AS |
$17.43 |
$582,755 |
I/I |
(33,434) |
2,488,011 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-26 |
4 |
AS |
$16.83 |
$807,857 |
I/I |
(48,001) |
2,521,445 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-23 |
4 |
AS |
$16.23 |
$500,549 |
I/I |
(30,841) |
2,569,446 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2017-06-22 |
4 |
AS |
$16.21 |
$24,753 |
I/I |
(1,527) |
2,600,287 |
|
- |
|
| Novak Rodger |
Chief Executive Officer |
• • – |
2017-06-22 |
4 |
AS |
$15.37 |
$166,388 |
D/D |
(10,825) |
1,215,005 |
|
- |
|
| Novak Rodger |
Chief Executive Officer |
• • – |
2017-06-22 |
4 |
OE |
$1.81 |
$19,593 |
D/D |
10,825 |
1,225,830 |
|
- |
|
| Novak Rodger |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
AS |
$15.02 |
$173,846 |
D/D |
(11,578) |
1,215,005 |
|
- |
|
| Novak Rodger |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
OE |
$1.81 |
$20,956 |
D/D |
11,578 |
1,266,583 |
|
- |
|
483 Records found
|
|
Page 16 of 20 |
|
|
2.04 (3.73%) 
